SG Americas Securities
AURA icon

SG Americas Securities’s Aura Biosciences AURA Stock Holding History

SG Americas Securities’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,198
Closed -$77K – 2935
2025
Q1 		$77K Sell
13,198
-4,092
-24% -$31K ﹤0.01% 3126
2024
Q4 		$142K Sell
17,290
-1,679
-9% -$15.8K ﹤0.01% 2453
2024
Q3 		$169K Buy
+18,969
New +$163K ﹤0.01% 2624
2024
Q2 		– Sell
-12,402
Closed -$97K – 2847
2024
Q1 		$97K Sell
12,402
-6,738
-35% -$55.9K ﹤0.01% 2577
2023
Q4 		$170K Buy
19,140
+6,546
+52% +$55.4K ﹤0.01% 2311
2023
Q3 		$113K Buy
+12,594
New +$135K ﹤0.01% 2707
2023
Q2 		– Sell
-11,201
Closed -$104K – 2301
2023
Q1 		$104K Buy
+11,201
New +$116K ﹤0.01% 2879

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SG Americas Securities's AURA Position: Q2 2025 in Review

SG Americas Securities sold out of Aura Biosciences (AURA) in Q2 2025, closing a stake of 13,198 shares — an estimated $77K sold.

SG Americas Securities first reported a position in AURA in Q1 2023 and held it in 7 quarters. The position peaked at $170K in Q4 2023. 104 funds tracked by Wall St. Rank hold AURA as of Q2 2025.

  • SG Americas Securities reported no remaining Aura Biosciences position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 13,198 Aura Biosciences shares in Q2 2025, an estimated $77K.
  • SG Americas Securities first reported a position in Aura Biosciences in Q1 2023 and held it in 7 quarters.
  • SG Americas Securities's Aura Biosciences position peaked at $170K in Q4 2023.
  • 104 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.